Literature DB >> 17386233

[Utility of myocardial perfusion scintigraphy in the emergency department for evaluation of patients with chest pain].

J M Jiménez-Hoyuela García1, J Robledo Carmona, M D Martínez Del Valle Torres, S Ortega Lozano, A Delgado García, J J Gómez Doblas.   

Abstract

OBJECTIVE: To evaluate diagnostic efficacy of rest myocardial perfusion scintigraphy in the detection of acute coronary syndrome in patients with chest pain and non diagnostic electrocardiogram, comparing it with reference techniques, in Emergency Department.
MATERIAL AND METHODS: Myocardial perfusion scintigraphy was carried out in 40 patients with those defined characteristics in the Emergency Department, administering the radiopharmaceutical in the next 6 hours after the pain was over. All subjects followed routine diagnostic and treatment management. Final diagnosis of coronary disease was established by coronariography and/or stress perfusion myocardial scintigraphy. Patients were followed up for 9-12 months.
RESULTS: Myocardial perfusion scintigraphy showed a negative predictive value of 96,15 % (CI 95 %: 86.84-100.00). The main limitation of its application was breast and diaphragmatic attenuation phenomenon, given that correction algorithms were not available. Global kappa coefficient was 0.78 when to compared interobserver agreement.
CONCLUSION: Rest myocardial perfusion scintigraphy is a safe and efficient test in the screening of patients with chest pain suggestive of angor with non-diagnostic ECG in Emergency Department, and also provides prognostic information and risk stratification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17386233

Source DB:  PubMed          Journal:  Rev Esp Med Nucl        ISSN: 0212-6982


  1 in total

1.  Negative predictive value and potential cost savings of acute nuclear myocardial perfusion imaging in low risk patients with suspected acute coronary syndrome: a prospective single blinded study.

Authors:  Jakob L Forberg; Catarina E Hilmersson; Marcus Carlsson; Håkan Arheden; Jonas Björk; Krister Hjalte; Ulf Ekelund
Journal:  BMC Emerg Med       Date:  2009-06-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.